Advertisement
Opthea Limited

Opthea Limited Fundamental Analysis

OPT.AXASX
HealthcareBiotechnology
$0.60
$0.00(0.00%)
Australian Market opens in 17h 13m
Advertisement

Opthea Limited Fundamental Analysis

Opthea Limited (OPT.AX) shows strong financial fundamentals with a PE ratio of -6.36, profit margin of 1222.32%, and ROE of 44.23%. The company generates $-0.0B in annual revenue with weak year-over-year growth of -79.95%.

Key Strengths

ROE44.23%
Operating Margin1597.70%
PEG Ratio-0.09

Areas of Concern

Current Ratio0.22
We analyze OPT.AX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -11.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-11.7/100

We analyze OPT.AX's fundamental strength across five key dimensions:

Efficiency Score

Weak

OPT.AX struggles to generate sufficient returns from assets.

ROA > 10%
-1.44%

Valuation Score

Excellent

OPT.AX trades at attractive valuation levels.

PE < 25
-6.36
PEG Ratio < 2
-0.09

Growth Score

Moderate

OPT.AX shows steady but slowing expansion.

Revenue Growth > 5%
-79.95%
EPS Growth > 10%
62.86%

Financial Health Score

Moderate

OPT.AX shows balanced financial health with some risks.

Debt/Equity < 1
-1.23
Current Ratio > 1
0.22

Profitability Score

Moderate

OPT.AX maintains healthy but balanced margins.

ROE > 15%
44.23%
Net Margin ≥ 15%
1222.32%
Positive Free Cash Flow
No

Key Financial Metrics

Is OPT.AX Expensive or Cheap?

P/E Ratio

OPT.AX trades at -6.36 times earnings. This suggests potential undervaluation.

-6.36

PEG Ratio

When adjusting for growth, OPT.AX's PEG of -0.09 indicates potential undervaluation.

-0.09

Price to Book

The market values Opthea Limited at -2.59 times its book value. This may indicate undervaluation.

-2.59

EV/EBITDA

Enterprise value stands at -2.44 times EBITDA. This is generally considered low.

-2.44

How Well Does OPT.AX Make Money?

Net Profit Margin

For every $100 in sales, Opthea Limited keeps $1222.32 as profit after all expenses.

1222.32%

Operating Margin

Core operations generate 1597.70 in profit for every $100 in revenue, before interest and taxes.

1597.70%

ROE

Management delivers $44.23 in profit for every $100 of shareholder equity.

44.23%

ROA

Opthea Limited generates $-1.44 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.44%

Following the Money - Real Cash Generation

Operating Cash Flow

Opthea Limited generates strong operating cash flow of $-136.79M, reflecting robust business health.

$-136.79M

Free Cash Flow

Opthea Limited generates strong free cash flow of $-133.86M, providing ample flexibility for dividends, buybacks, or growth.

$-133.86M

FCF Per Share

Each share generates $-0.10 in free cash annually.

$-0.10

FCF Yield

OPT.AX converts -20.88% of its market value into free cash.

-20.88%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-6.36

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.09

vs 25 benchmark

P/B Ratio

Price to book value ratio

-2.59

vs 25 benchmark

P/S Ratio

Price to sales ratio

-8638.95

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.23

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.22

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.44

vs 25 benchmark

ROA

Return on assets percentage

-1.44

vs 25 benchmark

ROCE

Return on capital employed

0.53

vs 25 benchmark

How OPT.AX Stacks Against Its Sector Peers

MetricOPT.AX ValueSector AveragePerformance
P/E Ratio-6.3629.34 Better (Cheaper)
ROE44.23%688.00% Weak
Net Margin122231.66%-52372.00% (disorted) Strong
Debt/Equity-1.230.49 Strong (Low Leverage)
Current Ratio0.224.37 Weak Liquidity
ROA-144.27%-20476.00% (disorted) Weak

OPT.AX outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Opthea Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-96.36%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-114.84%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-309.31%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ